ANDREW MANN: Open Payments
NPI 1740266436 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 44 payments from 8 companies in 2025. Trend: 2023 $1,511 · 2024 $1,485 · 2025 $1,154
Food & beverage: $1,148Education: $5
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $296 |
| Otsuka America Pharmaceutical, Inc. | 19 | $258 |
| Alkermes, Inc. | 8 | $248 |
| Janssen Pharmaceuticals, Inc | 5 | $178 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| ABBVIE INC. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Auvelity, REXULTI, INVEGA SUSTENNA, LYBALVI, COBENFY, VIVITROL, ARISTADA, VRAYLAR.
Industry payments across MA — which companies pay providers there.
